Serum Calprotectin in Surgical Septic Patients

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAzienda Ospedaliero, Universitaria Pisana

About this trial

To early evaluate the serum levels of calprotectin in patients suffering from intra-abdominal sepsis requiring a surgical treatment. The research project aims to investigate the role of serum calprotectin in the diagnosis of sepsis and to establish whether its level significantly correlates with different degree of disease severity and with short and long-term outcomes. If these associations were confirmed, serum calprotectin would represent an easily and rapidly detectable biomarker able to predict the severity of sepsis.

Eligibility criteria

Qualifiers

diagnosis of upper/lower gastro-intestinal perforation

diagnosis of intestinal occlusion

diagnosis of acute cholecystitis

diagnosis of complicated acute appendicitis

Disqualifiers

recent (<3 months) surgery

recent (<3 months) trauma

diagnosis of acute pancreatitis

diagnosis of burn

Trial design

Treatments tested in this trial

  • serum calprotectin

Treatment groups

150 Participants
are divided into 3 treatment groups